Pediatric Preclinical Testing Consortium evaluation of the AZD1775 as a single agent and in combination with irinotecan

被引：1
|
作者：
Houghton, Peter J. [1 ]
Kurmasheva, Raushan T. [1 ]
Gorlick, Richard [2 ]
Kolb, E. Anders [3 ]
Mosse, Yael P. [4 ]
Erickson, Stephen W. [5 ]
Guo, Yuelong [5 ]
Teicher, Beverly A. [6 ]
Smith, Malcolm A. [6 ]
Maris, John M. [4 ]
机构：
[1] Greehey Childrens Canc Res Inst, San Antonio, TX USA
[2] MD Anderson, Houston, TX USA
[3] Nemours Ctr Canc & Blood Disorders, Wilmington, DE USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[5] RTI Int, Res Triangle Pk, NC USA
[6] NCI, Bethesda, MD 20892 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-LB-B15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-B15
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium
    Harrison, Douglas J.
    Gill, Jonathan D.
    Roth, Michael E.
    Zhang, Wendong
    Teicher, Beverly
    Erickson, Stephen
    Gatto, Greg
    Kurmasheva, Raushan T.
    Houghton, Peter J.
    Smith, Malcolm A.
    Kolb, Edward Anders
    Gorlick, Richard
    PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [32] Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
    Guertin, Amy D.
    Li, Jing
    Liu, Yaping
    Hurd, Melissa S.
    Schuller, Alwin G.
    Long, Brian
    Hirsch, Heather A.
    Feldman, Igor
    Benita, Yair
    Toniatti, Carlo
    Zawel, Leigh
    Fawell, Stephen E.
    Gilliland, D. Gary
    Shumway, Stuart D.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1442 - 1452
  • [33] Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
    Cuneo, Kyle C.
    Morgan, Meredith A.
    Sahai, Vaibhav
    Schipper, Matthew J.
    Parsels, Leslie A.
    Parsels, Joshua D.
    Devasia, Theresa
    Al-Hawaray, Mahmoud
    Cho, Clifford S.
    Nathan, Hari
    Maybaum, Jonathan
    Zalupski, Mark M.
    Lawrence, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) : 2643 - +
  • [34] A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells (vol 11, pg 921, 2016)
    Matheson, Christopher J.
    Venkataraman, Sujatha
    Amani, Vladimir
    Harris, Peter S.
    Backos, Donald S.
    Donson, Andrew M.
    Wempe, Michael F.
    Foreman, Nicholas K.
    Vibhakar, Rajeev
    Reigan, Philip
    ACS CHEMICAL BIOLOGY, 2016, 11 (07) : 2066 - 2067
  • [35] Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium
    Gill, Jonathan
    Zhang, Wendong
    Zhang, Zhongting
    Roth, Michael
    Harrison, Douglas J.
    Rowshan, Sudie
    Erickson, Stephen
    Gatto, Gregory
    Kurmasheva, Raushan
    Houghton, Peter
    Teicher, Beverly
    Smith, Malcolm A.
    Kolb, E. Anders
    Gorlick, Richard
    PEDIATRIC BLOOD & CANCER, 2020, 67 (10)
  • [36] Preclinical testing of lestaurtinib (CEP701) as a single and combination agent for the treatment of Ewing sarcoma
    Dayi, Samet
    Schaefer, Christiane
    Albers, Anne
    Balusamy, Kiruthiga
    Hotfilder, Marc
    Kerkhoff, Maximilian
    Koch, Leonhard
    Onder, Hatice
    Rossig, Claudia
    Dirksen, Uta
    Zollner, Stefan K.
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Phase II trial of AZD1775 in combination with carboplatin and paclitaxel in stage IV squamous cell lung cancer (sqNSCLC): Preliminary results.
    Gray, Jhanelle Elaine
    Tanvetyanon, Tawee
    Creelan, Ben C.
    Antonia, Scott Joseph
    Haura, Eric B.
    Williams, Charles C.
    Yaseen, Raheel
    Schell, Michael J.
    Godin, Robert
    Rix, Uwe
    Monteiro, Alvaro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma
    Mendez, Eduardo
    Rodriguez, Cristina P.
    Kao, Michael C.
    Raju, Sharat
    Diab, Ahmed
    Harbison, R. Alex
    Konnick, Eric Q.
    Mugundu, Ganesh M.
    Santana-Davila, Rafael
    Martins, Renato
    Futran, Neal D.
    Chow, Laura Q. M.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2740 - 2748
  • [39] WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer
    Richer, Amanda L.
    Cala, Jacqueline M.
    O'Brien, Kelley
    Carson, Vashti M.
    Inge, Landon J.
    Whitsett, Timothy G.
    CANCER RESEARCH, 2017, 77 (17) : 4663 - 4672
  • [40] A phase I clinical trial of AZD1775 in combination with neoadjuvant weekly cisplatin and docetaxel in borderline resectable head and neck squamous cell carcinoma (HNSCC).
    Mendez, Eduardo
    Rodriguez, Cristina P.
    Kao, Michael
    Harbison, Richard A.
    Martins, Renato G.
    Futran, Neal D.
    Santana-Davila, Rafael
    Chow, Laura Quan Man
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345